(AMEM) Amundi MSCI Emerging Markets - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1681045370 • Global Emerging Markets Equity
AMEM: Stocks, Bonds, Emerging Markets, Equities
The Amundi MSCI Emerging Markets UCITS ETF (XETRA: AMEM) is a straightforward investment vehicle designed for those seeking exposure to emerging markets. With an AUM of 1.9 billion EUR, it offers substantial liquidity and a diversified portfolio, reflecting the performance of its underlying Morningstar EM Net Total Return USD Index. This ETF is structured as a UCITS, complying with European regulations, which ensures transparency and regulatory oversight, making it accessible and reliable for European investors.
Emerging markets present a compelling opportunity for growth, often outpacing developed markets due to their earlier stages of economic development. However, this potential comes with higher volatility and risks such as political instability and currency fluctuations. The ETFs expense ratio is a critical factor to consider, as lower fees can significantly impact long-term returns. Additionally, the tracking error relative to its benchmark is an important metric, indicating how closely the ETF mirrors the indexs performance.
Naval Ravikant often emphasizes the importance of a long-term perspective and diversification. This ETF aligns with those principles, offering strategic allocation to enhance portfolio diversification and potentially increase returns. By holding a broad range of emerging market equities, it allows investors to capture growth across various regions without the complexities of selecting individual stocks. For those considering emerging markets, a buy-and-hold strategy is advisable, given the markets volatility and the benefits of compounding over time.
Additional Sources for AMEM ETF
AMEM ETF Overview
Market Cap in USD | 2,070m |
Category | Global Emerging Markets Equity |
TER | 0.20% |
IPO / Inception | 2018-04-18 |
AMEM ETF Ratings
Growth 5y | 43.6% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -12.1 |
Analysts | - |
Fair Price Momentum | 4.79 EUR |
Fair Price DCF | - |
AMEM Dividends
No Dividends PaidAMEM Growth Ratios
Growth Correlation 3m | 26.2% |
Growth Correlation 12m | 80.4% |
Growth Correlation 5y | 25.9% |
CAGR 5y | 9.05% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 0.96 |
Alpha | 3.20 |
Beta | 0.65 |
Volatility | 17.43% |
Current Volume | 37k |
Average Volume 20d | 123.3k |
As of March 14, 2025, the stock is trading at EUR 5.14 with a total of 36,978 shares traded.
Over the past week, the price has changed by -1.89%, over one month by -4.27%, over three months by -2.25% and over the past year by +9.78%.
Partly, yes. Based on ValueRay Analyses, Amundi MSCI Emerging Markets (XETRA:AMEM) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.56 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMEM as of March 2025 is 4.79. This means that AMEM is currently overvalued and has a potential downside of -6.81%.
Amundi MSCI Emerging Markets has no consensus analysts rating.
According to ValueRays Forecast Model, AMEM Amundi MSCI Emerging Markets will be worth about 5.3 in March 2026. The stock is currently trading at 5.14. This means that the stock has a potential upside of +3.31%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 5.3 | 3.3% |